"Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01694433|
Recruitment Status : Unknown
Verified February 2013 by Jenny Kim, MD, PhD, University of California, Los Angeles.
Recruitment status was: Active, not recruiting
First Posted : September 27, 2012
Last Update Posted : October 21, 2013
|Condition or disease||Intervention/treatment||Phase|
|Acne Vulgaris||Drug: Calcipotriene Drug: Placebo||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||54 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Innate Immunity in Acne Vulgaris|
|Study Start Date :||February 2013|
|Estimated Primary Completion Date :||January 2014|
|Estimated Study Completion Date :||December 2014|
Experimental: Calcipotriene Cream
The Calcipotriene Cream will be supplied as 1g daily use individual tubes to be used 2x/day (once in the morning and once in the evening) for 12 weeks.
1g daily BID
Placebo Comparator: Placebo
The Placebo Cream will be supplied as 1g daily use individual tubes to be used 2x/day (once in the morning and once in the evening) for 12 weeks.
1g daily BID
Other Name: Placebo cream manufactured to mimic calcipotriene
- Determine the clinical efficacy of a topical vitamin D analogue for acne therapy by assessing lesion counts (total, inflammatory and non-inflammatory) [ Time Frame: 12 weeks ]
- Clinical Global Improvement (CGI) score [ Time Frame: 12 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01694433
|United States, California|
|Los Angeles, California, United States, 90095|
|Principal Investigator:||Jenny Kim, MD||UCLA Department of Dermatology|